Clinical Trials in DR

Diabetic Retinopathy Clinical Studies

Diabetic retinopathy (DR) is a complication of diabetes that causes damage to the blood vessels of the retina; it is the most common cause of irreversible blindness in working-age Americans. [ASRS.2016]. Vascular endothelial growth factor (VEGF) plays a critical role in promoting angiogenesis and vascular leakage, and several different anti-VEGF agents have been studied in the management of DME, PDR and advanced NPDR.

This section lists the most relevant clinical studies in DR/DME; click on the study name to see more details about each particular study. To enhance visibility of graphs and tables, click on the image to enlarge for expanding viewing.

More DR Clinical Studies

References